motapizone has been researched along with rp 73401 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Branscheid, D; Dent, G; Magnussen, H; Rabe, KF; Rühlmann, E; Schmidt, DT; Watson, N | 1 |
| Dunkern, T; Hatzelmann, A; Selige, J; Tenor, H | 1 |
2 other study(ies) available for motapizone and rp 73401
| Article | Year |
|---|---|
The effect of selective and non-selective phosphodiesterase inhibitors on allergen- and leukotriene C(4)-induced contractions in passively sensitized human airways.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Antigens, Dermatophagoides; Benzamides; Bronchi; Bronchodilator Agents; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Glycoproteins; Histamine; Humans; In Vitro Techniques; Leukotriene C4; Lung Neoplasms; Muscle Contraction; Phosphodiesterase Inhibitors; Pyridazines; Pyridines; Rolipram; Theophylline | 2000 |
Cytokine-dependent balance of mitogenic effects in primary human lung fibroblasts related to cyclic AMP signaling and phosphodiesterase 4 inhibition.
Topics: Benzamides; Cell Proliferation; Cells, Cultured; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclooxygenase 2; Cytokines; Dinoprostone; DNA Replication; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Fibroblast Growth Factor 2; Fibroblasts; Genes, cdc; Growth Substances; Humans; Interleukin-1beta; Lung; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 4 Inhibitors; Pulmonary Fibrosis; Pyridazines; Pyridines; Signal Transduction | 2010 |